ReP USP - Resultado da busca

Artigo de periodico
An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria (2022)
Lau, Leyre Pernaute ; Camara, Mahamadou ; Sousa, Taís Nóbrega de; Morris, Ulrika ; Ferreira, Marcelo Urbano ; Gil, José Pedro
Source: Expert Opinion on Drug Metabolism & Toxicology. Unidade: ICB
Subjects: MICROBIOLOGIA, FARMACOGENÉTICA, MEDICAMENTO, ANTIMALÁRICOS, MALÁRIA FALCIPARUM, PLASMODIUM FALCIPARUM, MALÁRIA, RESISTÊNCIA MICROBIANA ÀS DROGAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LAU, Leyre Pernaute et al. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opinion on Drug Metabolism & Toxicology, v. 18, n. 1, p. 39-59, 2022Tradução . . Disponível em: https://doi.org/10.1080/17425255.2022.2049235. Acesso em: 16 nov. 2024.
APA
Lau, L. P., Camara, M., Sousa, T. N. de, Morris, U., Ferreira, M. U., & Gil, J. P. (2022). An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria. Expert Opinion on Drug Metabolism & Toxicology, 18( 1), 39-59. doi:10.1080/17425255.2022.2049235
NLM
Lau LP, Camara M, Sousa TN de, Morris U, Ferreira MU, Gil JP. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2022 ; 18( 1): 39-59.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1080/17425255.2022.2049235
Vancouver
Lau LP, Camara M, Sousa TN de, Morris U, Ferreira MU, Gil JP. An update on pharmacogenetic factors influencing the metabolism and toxicity of artemisinin-based combination therapy in the treatment of malaria [Internet]. Expert Opinion on Drug Metabolism & Toxicology. 2022 ; 18( 1): 39-59.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1080/17425255.2022.2049235
Artigo de periodico
Violacein-Induced chaperone system collapse underlies multistage antiplasmodial activity (2021)
Tavella, Tatyana Almeida ; Silva, Noeli Soares Melo da ; Spillman, Natalie ; Kayano, Ana Carolina Andrade Vitor ; Cassiano, Gustavo Capatti ; Vasconcelos, Adrielle Ayumi ; Camargo, Antônio Pedro ; Silva, Djane Clarys Baia da ; Fontinha, Diana ; Alvarez, Luis Carlos Salazar ; Ferreira, Letícia Tiburcio ; Tomaz, Kaira Cristina Peralis ; Neves, Bruno Junior ; Almeida, Ludimila Dias; Bargieri, Daniel Youssef ; Lacerda, Marcus Vinicius Guimarães de ; Cravo, Pedro Vitor Lemos ; Sunnerhagen, Per ; Prudencio, Miguel ; Andrade, Carolina Horta ; Lopes, Stefanie Costa Pinto ; Carazzolle, Marcelo Falsarella; Tilley, Leann ; Bilsland, Elizabeth ; Borges, Julio Cesar ; Costa, Fabio Trindade Maranhão
Source: ACS Infectious Diseases. Unidades: ICB, IQSC
Subjects: MALÁRIA, PROTEÍNAS, PARASITOLOGIA, ANTIMALÁRICOS, CÉLULAS CULTIVADAS DE TUMOR, PLASMODIUM FALCIPARUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVELLA, Tatyana Almeida et al. Violacein-Induced chaperone system collapse underlies multistage antiplasmodial activity. ACS Infectious Diseases, v. 7, n. 4, p. 759–776, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.0c00454. Acesso em: 16 nov. 2024.
APA
Tavella, T. A., Silva, N. S. M. da, Spillman, N., Kayano, A. C. A. V., Cassiano, G. C., Vasconcelos, A. A., et al. (2021). Violacein-Induced chaperone system collapse underlies multistage antiplasmodial activity. ACS Infectious Diseases, 7( 4), 759–776. doi:10.1021/acsinfecdis.0c00454
NLM
Tavella TA, Silva NSM da, Spillman N, Kayano ACAV, Cassiano GC, Vasconcelos AA, Camargo AP, Silva DCB da, Fontinha D, Alvarez LCS, Ferreira LT, Tomaz KCP, Neves BJ, Almeida LD, Bargieri DY, Lacerda MVG de, Cravo PVL, Sunnerhagen P, Prudencio M, Andrade CH, Lopes SCP, Carazzolle MF, Tilley L, Bilsland E, Borges JC, Costa FTM. Violacein-Induced chaperone system collapse underlies multistage antiplasmodial activity [Internet]. ACS Infectious Diseases. 2021 ; 7( 4): 759–776.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00454
Vancouver
Tavella TA, Silva NSM da, Spillman N, Kayano ACAV, Cassiano GC, Vasconcelos AA, Camargo AP, Silva DCB da, Fontinha D, Alvarez LCS, Ferreira LT, Tomaz KCP, Neves BJ, Almeida LD, Bargieri DY, Lacerda MVG de, Cravo PVL, Sunnerhagen P, Prudencio M, Andrade CH, Lopes SCP, Carazzolle MF, Tilley L, Bilsland E, Borges JC, Costa FTM. Violacein-Induced chaperone system collapse underlies multistage antiplasmodial activity [Internet]. ACS Infectious Diseases. 2021 ; 7( 4): 759–776.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1021/acsinfecdis.0c00454
Artigo de periodico
Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions (2021)
Ferreira, Marcelo Urbano ; Sousa, Tais Nobrega de; Rangel, Gabriel W. ; Johansen, Igor Cavallini ; Corder, Rodrigo Malavazi ; Andrade, Simone Ladeia ; Gil, José Pedro
Source: International Journal for Parasitology: Drugs and Drug Resistance. Unidade: ICB
Subjects: PARASITOLOGIA, ANTIMALÁRICOS, PLASMODIUM, INFECÇÕES POR PROTOZOÁRIOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, MARCADOR MOLECULAR, FENÓTIPOS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Marcelo Urbano et al. Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions. International Journal for Parasitology: Drugs and Drug Resistance, v. 15, p. 9-24, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ijpddr.2020.12.001. Acesso em: 16 nov. 2024.
APA
Ferreira, M. U., Sousa, T. N. de, Rangel, G. W., Johansen, I. C., Corder, R. M., Andrade, S. L., & Gil, J. P. (2021). Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions. International Journal for Parasitology: Drugs and Drug Resistance, 15, 9-24. doi:10.1016/j.ijpddr.2020.12.001
NLM
Ferreira MU, Sousa TN de, Rangel GW, Johansen IC, Corder RM, Andrade SL, Gil JP. Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions [Internet]. International Journal for Parasitology: Drugs and Drug Resistance. 2021 ; 15 9-24.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijpddr.2020.12.001
Vancouver
Ferreira MU, Sousa TN de, Rangel GW, Johansen IC, Corder RM, Andrade SL, Gil JP. Monitoring Plasmodium vivax resistance to antimalarials: persisting challenges and future directions [Internet]. International Journal for Parasitology: Drugs and Drug Resistance. 2021 ; 15 9-24.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijpddr.2020.12.001
Artigo de periodico
A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity (2020)
Wylensek, David; Hitch, Thomas C. A. ; Riedel, Thomas; Afrizal, Afrizal ; Kumar, Neeraj; Wortmann, Esther ; Liu, Tianzhe; Devendran, Saravanan ; Lesker, Till R. ; Hernández, Sara B. ; Heine, Viktoria ; Buhl, Eva Miriam ; D’Agostino, Paul Miguel ; Cumbo, Fabio ; Fischöder, Thomas ; Wyschkon, Marzena; Looft, Torey ; Parreira, Valeria R. ; Abt, Birte; Doden, Heidi L. ; Ly, Lindsey ; Alves, João Marcelo Pereira ; Reichlin, Markus; Flisikows, kiKrzysztof; Suarez, Laura Navarro; Neumann, Anthony P. ; Suen, Garret ; Wouters, Tomas de ; Rohn, Sascha ; Lagkouvardos, Ilias ; Vercoe, Emma Allen ; Spröer, Cathrin; Bunk, Boyke ; Thiele, Anja J. Taverne; Giesbers, Marcel; Wells, Jerry M.; Neuhaus, Klaus ; Schnieke, Angelika ; Cava, Felipe ; Segata, Nicola ; Elling, Lothar ; Strowig, Till ; Ridlon, Jason M. ; Gulder, Tobias A. M. ; Overmann, Jörg ; Clavel, Thomas
Source: Nature Communications. Unidade: ICB
Subjects: PARASITOLOGIA, SUÍNOS, ENTEROPATIAS EM ANIMAL, LACTOBACILLUS, GENÉTICA BACTERIANA, GENOMAS, SEQUENCIAMENTO GENÉTICO, PEPTÍDEO INTESTINAL VASOATIVO, INTESTINO DE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WYLENSEK, David et al. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity. Nature Communications, v. 11, p. 26 , 2020Tradução . . Disponível em: https://doi.org/10.1038/s41467-020-19929-w. Acesso em: 16 nov. 2024.
APA
Wylensek, D., Hitch, T. C. A., Riedel, T., Afrizal, A., Kumar, N., Wortmann, E., et al. (2020). A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity. Nature Communications, 11, 26 . doi:10.1038/s41467-020-19929-w
NLM
Wylensek D, Hitch TCA, Riedel T, Afrizal A, Kumar N, Wortmann E, Liu T, Devendran S, Lesker TR, Hernández SB, Heine V, Buhl EM, D’Agostino PM, Cumbo F, Fischöder T, Wyschkon M, Looft T, Parreira VR, Abt B, Doden HL, Ly L, Alves JMP, Reichlin M, Flisikows kiK, Suarez LN, Neumann AP, Suen G, Wouters T de, Rohn S, Lagkouvardos I, Vercoe EA, Spröer C, Bunk B, Thiele AJT, Giesbers M, Wells JM, Neuhaus K, Schnieke A, Cava F, Segata N, Elling L, Strowig T, Ridlon JM, Gulder TAM, Overmann J, Clavel T. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity [Internet]. Nature Communications. 2020 ; 11 26 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41467-020-19929-w
Vancouver
Wylensek D, Hitch TCA, Riedel T, Afrizal A, Kumar N, Wortmann E, Liu T, Devendran S, Lesker TR, Hernández SB, Heine V, Buhl EM, D’Agostino PM, Cumbo F, Fischöder T, Wyschkon M, Looft T, Parreira VR, Abt B, Doden HL, Ly L, Alves JMP, Reichlin M, Flisikows kiK, Suarez LN, Neumann AP, Suen G, Wouters T de, Rohn S, Lagkouvardos I, Vercoe EA, Spröer C, Bunk B, Thiele AJT, Giesbers M, Wells JM, Neuhaus K, Schnieke A, Cava F, Segata N, Elling L, Strowig T, Ridlon JM, Gulder TAM, Overmann J, Clavel T. A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity [Internet]. Nature Communications. 2020 ; 11 26 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41467-020-19929-w
Artigo de periodico
Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax (2020)
Ferreira, Letícia Tiburcio ; Rodrigues, Juliana; Cassiano, Gustavo Capatti ; Tavella, Tatyana Almeida ; Tomaz, Kaira Cristina Peralis; Silva, Djane Clarys Baia da ; Souza, Macejane Ferreira; Lima, Marilia Nunes do Nascimento; Mottin, Melina ; Almeida, Ludimila Dias; Paim, Juliana Calit ; Puça, Maria Carolina Silva de Barros; Melo, Gisely Cardoso; Bargieri, Daniel Youssef ; Lopes, Stefanie Costa Pinto ; Lacerda, Marcus Vinicius Guimarães ; Bilsland, Elizabeth ; Sunnerhagen, Per ; Neves, Bruno Junior ; Andrade, Carolina Horta ; Cravo, Pedro Vitor Lemo ; Costa, Fabio Trindade Maranhão
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, MALÁRIA, ANTIMALÁRICOS, PLASMODIUM FALCIPARUM, MEDICAMENTO, RESISTÊNCIA MICROBIANA ÀS DROGAS, REPLICAÇÃO DO DNA, ATIVAÇÃO ENZIMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Letícia Tiburcio et al. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, v. 64, n. 9, p. 16 , 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.02041-19. Acesso em: 16 nov. 2024.
APA
Ferreira, L. T., Rodrigues, J., Cassiano, G. C., Tavella, T. A., Tomaz, K. C. P., Silva, D. C. B. da, et al. (2020). Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax. Antimicrobial Agents and Chemotherapy, 64( 9), 16 . doi:10.1128/AAC.02041-19
NLM
Ferreira LT, Rodrigues J, Cassiano GC, Tavella TA, Tomaz KCP, Silva DCB da, Souza MF, Lima MN do N, Mottin M, Almeida LD, Paim JC, Puça MCS de B, Melo GC, Bargieri DY, Lopes SCP, Lacerda MVG, Bilsland E, Sunnerhagen P, Neves BJ, Andrade CH, Cravo PVL, Costa FTM. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 9): 16 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1128/AAC.02041-19
Vancouver
Ferreira LT, Rodrigues J, Cassiano GC, Tavella TA, Tomaz KCP, Silva DCB da, Souza MF, Lima MN do N, Mottin M, Almeida LD, Paim JC, Puça MCS de B, Melo GC, Bargieri DY, Lopes SCP, Lacerda MVG, Bilsland E, Sunnerhagen P, Neves BJ, Andrade CH, Cravo PVL, Costa FTM. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium Falciparum and P. vivax [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 9): 16 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.1128/AAC.02041-19
Artigo de periodico
Protein paucimannosylation is an enriched N-gycosylation signature of human cancers (2019)
Chatterjee, Sayantani ; Lee, Ling Y. ; Kawahara, Rebeca ; Abrahams, Jodie L. ; Adamczyk, Barbara ; Anugraham, Merrina ; Ashwood, Christopher ; Sumer‐Bayraktar, Zeynep ; Briggs, Matthew T. ; Chik, Jenny H. L. ; Everest‐Dass, Arun ; Förster, Sarah; Hinneburg, Hannes; Leite, Katia Ramos Moreira ; Loke, Ian ; Möginger, Uwe; Moh, Edward S. X. ; Nakano, Miyako; Recuero, Saulo; Sethi, Manveen K. ; Srougi, Miguel ; Stavenhagen, Kathrin ; Venkatakrishnan, Vignesh ; Wongtrakul‐Kish, Katherine ; Diestel, Simone ; Hoffmann, Peter; Karlsson, Niclas G. ; Kolarich, Daniel ; Molloy, Mark P. ; Muders, Michael H.; Oehler, Martin K. ; Packer, Nicolle H. ; Palmisano, Giuseppe ; Thaysen‐Andersen, Morten
Source: Proteomics. Unidades: FM, ICB
Subjects: PARASITOLOGIA, NEOPLASIAS, LEUCEMIA, NEOPLASIAS HEPÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHATTERJEE, Sayantani et al. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers. Proteomics, p. 1-13, 2019Tradução . . Disponível em: https://doi.org/10.1002/pmic.201900010. Acesso em: 16 nov. 2024.
APA
Chatterjee, S., Lee, L. Y., Kawahara, R., Abrahams, J. L., Adamczyk, B., Anugraham, M., et al. (2019). Protein paucimannosylation is an enriched N-gycosylation signature of human cancers. Proteomics, 1-13. doi:10.1002/pmic.201900010
NLM
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers [Internet]. Proteomics. 2019 ; 1-13.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/pmic.201900010
Vancouver
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers [Internet]. Proteomics. 2019 ; 1-13.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/pmic.201900010
Artigo de periodico
Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan (2018)
Bilsland, Elizabeth; Vliet, Liisa van; Williams, Kevin; Feltham, Jack; Carrasco, Marta P.; Fotoran, Wesley L.; Cubillos, Eliana F. G.; Wunderlich, Gerhard ; Grøtli, Morten; Hollfelder, Florian; Jackson, Victoria; King, Ross D.; Oliver, Stephen G.
Source: Scientific Reports. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM FALCIPARUM, ANTIMALÁRICOS, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BILSLAND, Elizabeth et al. Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan. Scientific Reports, v. 8, p. 1-8, 2018Tradução . . Disponível em: https://doi.org/10.1038/s41598-018-19549-x. Acesso em: 16 nov. 2024.
APA
Bilsland, E., Vliet, L. van, Williams, K., Feltham, J., Carrasco, M. P., Fotoran, W. L., et al. (2018). Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan. Scientific Reports, 8, 1-8. doi:10.1038/s41598-018-19549-x
NLM
Bilsland E, Vliet L van, Williams K, Feltham J, Carrasco MP, Fotoran WL, Cubillos EFG, Wunderlich G, Grøtli M, Hollfelder F, Jackson V, King RD, Oliver SG. Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan [Internet]. Scientific Reports. 2018 ; 8 1-8.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-018-19549-x
Vancouver
Bilsland E, Vliet L van, Williams K, Feltham J, Carrasco MP, Fotoran WL, Cubillos EFG, Wunderlich G, Grøtli M, Hollfelder F, Jackson V, King RD, Oliver SG. Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan [Internet]. Scientific Reports. 2018 ; 8 1-8.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41598-018-19549-x
Artigo de periodico
Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies (2016)
Mita, Toshihiro; Culleton, Richard; Takahashi, Nobuyuki; Nakamura, Masatoshi; Tsukahara, Takahiro; Hunja, Carol W.; Win, Zin Zayar; Htike, Wah Win; Marma, Aung S.; Dysoley, Lek; Ndounga, Mathieu; Dzodzomenyo, Mawuli; Akhwale, Willis S.; Kobayashi, Jun; Uemura, Haruki; Kaneko, Akira; Hombhanje, Francis; Ferreira, Marcelo Urbano ; Björkman, Anders; Endo, Hiroyoshi; Ohashi, Jun
Source: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Subjects: PARASITOLOGIA, PLASMODIUM FALCIPARUM, MALÁRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MITA, Toshihiro et al. Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies. Antimicrobial Agents and Chemotherapy, v. 60, n. 6, p. 3340-3347, 2016Tradução . . Disponível em: https://doi.org/10.1128/AAC.02370-15. Acesso em: 16 nov. 2024.
APA
Mita, T., Culleton, R., Takahashi, N., Nakamura, M., Tsukahara, T., Hunja, C. W., et al. (2016). Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies. Antimicrobial Agents and Chemotherapy, 60( 6), 3340-3347. doi:10.1128/AAC.02370-15
NLM
Mita T, Culleton R, Takahashi N, Nakamura M, Tsukahara T, Hunja CW, Win ZZ, Htike WW, Marma AS, Dysoley L, Ndounga M, Dzodzomenyo M, Akhwale WS, Kobayashi J, Uemura H, Kaneko A, Hombhanje F, Ferreira MU, Björkman A, Endo H, Ohashi J. Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies [Internet]. Antimicrobial Agents and Chemotherapy. 2016 ; 60( 6): 3340-3347.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1128/AAC.02370-15
Vancouver
Mita T, Culleton R, Takahashi N, Nakamura M, Tsukahara T, Hunja CW, Win ZZ, Htike WW, Marma AS, Dysoley L, Ndounga M, Dzodzomenyo M, Akhwale WS, Kobayashi J, Uemura H, Kaneko A, Hombhanje F, Ferreira MU, Björkman A, Endo H, Ohashi J. Little Polymorphism at the K13 Propeller Locus in Worldwide Plasmodium falciparum Populations Prior to the Introduction of Artemisinin Combination Therapies [Internet]. Antimicrobial Agents and Chemotherapy. 2016 ; 60( 6): 3340-3347.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1128/AAC.02370-15

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration